Skip to content
Home/Companies/Biotech/Akero Therapeutics
Akero Therapeutics

Akero Therapeutics

Biotech·US·Active
Entry
–
Hold
–
Status
Active

Who owns Akero Therapeutics?

Akero Therapeutics is currently owned by General Atlantic through General Atlantic Growth Equity Fund (2024 vintage).

Hand-verified · updated 2026-04-21

General Atlantic
Investor
General Atlantic
General Atlantic Growth Equity Fund · 2024 · Growth

Key facts

HQUSA
SectorBiotech
Websiteakerotx.com

More from General Atlantic Growth Equity Fund

Other portfolio companies in the same fund.

A Place for Mom
A Place for Mom
Active
Business ServicesUS
Absolute Barbecue
Absolute Barbecue
Active
HospitalityIndia
Adyen
Active
TMTNetherlands
Alkami Technology
Alkami Technology
Active
SaaSUS
Amagi
Amagi
Active
TMTUS
Amherst Pierpont
Active
FinancialsUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Ariceum Therapeutics GmbH
Active
Enterprise IrelandGermany
Track Akero Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Akero Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Akero Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue